InnoCAT

Wearable Electromechanical Insulin Delivery Device

Health Tech & Life Sciences
Active
Seed Givat Ela Founded 2021
LinkedIn
Total raised
Last: Seed 2023-02
Stage
Seed
Founded
2021
Headcount
4
HQ
Givat Ela
Sector
Health Tech & Life Sciences

About

InnoCAT develops a wearable electromechanical device for insulin delivery, designed to simplify diabetes management while improving patient comfort and safety. The company’s proprietary pump architecture integrates user-centric design with efficient electromechanical components to achieve high wearability, usability, and reliability. InnoCAT emphasizes manufacturability and cost efficiency from the outset, ensuring a low cost of goods and scalable production. Its business model is built around profitability through design simplicity and streamlined assembly processes. By partnering with leading medical device manufacturers, InnoCAT aims to deliver a sustainable and commercially viable insulin pump that balances clinical performance with user convenience

Funding history · 1 round · — total

2023-02
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2CB2B2C

Tags

diabetesdrug-deliverytreatments